Global Clinical Nutrition Market Size Study & Forecast, By Product (Oral Clinical Nutrition, Parenteral Nutrition, Enteral Feeding Formulas) By Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases,

Global Clinical Nutrition Market Size Study & Forecast, By Product (Oral Clinical Nutrition, Parenteral Nutrition, Enteral Feeding Formulas) By Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others), By Sales (Retail Sales Channels, Online Sales Channels, Institutional Sales Channels) and Regional Analysis, 2023-2030

Global Clinical Nutrition Market is valued at approximately USD 29.12 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.34% over the forecast period 2023-2030. Clinical nutrition is a specialized branch of nutrition science that focuses on the application of dietary principles to prevent, manage, and treat various health conditions. It involves the assessment of an individual's nutritional needs, dietary habits, and overall health status to develop personalized nutrition plans. Clinical nutritionists work in collaboration with healthcare professionals to address specific medical concerns such as diabetes, cardiovascular diseases, obesity, and gastrointestinal disorders. They utilize their knowledge of biochemistry, physiology, and nutrition to design interventions that support optimal health and well-being. The Clinical Nutrition Market is expanding because of factors such as the rising prevalence of malnutrition, the increase in the prevalence of chronic diseases, and the rising geriatric population around the globe.

The rising prevalence of malnutrition is a significant driver behind the growth of the Clinical Nutrition Market. Malnutrition, characterized by deficiencies or imbalances in essential nutrients, poses a substantial global health challenge, affecting individuals across diverse age groups and populations. In light of the severe consequences of malnutrition, clinical nutrition must be emphasized and implemented as a crucial measure to effectively address and prevent this condition. Clinical nutrition products and interventions play a crucial role in delivering targeted nutritional support to individuals with malnutrition, whether caused by medical conditions, chronic diseases, or inadequate dietary intake. According to the World Health Organization's 2022 report, approximately 149 million children under the age of 5 were identified as stunted globally, with 45 million experiencing malnutrition. The South Asia sub-region bears a substantial burden of malnutrition among children in this age group. The United Nations reports a concerning trend in Asia, where the undernourished population rose from 361.3 million in 2019 to 418.0 million in 2020, leading to an increase in undernourishment from 7.9% to 9.0% during this period. Thus, rising prevalence of malnutrition is driving the market growth. In addition, technological advancements in nutrition science and increasing healthcare infrastructure are creating new opportunities for market growth. However, the high cost of clinical nutrition and stringent regulatory environment stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Nutrition Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. The market in the region is being driven by factors such as the increasing geriatric population, which is more susceptible to chronic diseases, such as gastrointestinal disorders, metabolic disorders, and neurological disorders and the growing number of premature infants in critical care is a major factor driving market growth. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as a rising geriatric population and, an increase in the prevalence of various diseases, such as cancer, diabetes, gastrointestinal disorders, and autoimmune diseases. As a result, the demand for clinical nutrition for the dietary management of chronic diseases is expected to increase.

Major market players included in this report are:
Abbott Nutrition (U.S)
Pfizer Inc. (U.S)
Bayer AG (Germany)
Nestle S.A (Switzerland)
Baxter International Inc. (U.S)
Otsuka Holdings Co., Ltd. (Japan)
Reckitt Benckiser Group Plc (UK)
Danone (Nutricia) (France)
Victus, Inc. (US)
Fresenius Kabi (Germany)

Recent Developments in the Market:
 In March 2023, Danone completed the acquisition of ProMedica, a Poland-based company specializing in offering in-home care services for patients. This strategic move aligns with Danone's robust expansion strategy in the specialized nutrition market, aimed at bolstering its footprint in Poland.
 In March 2022, the FDA approved Fresenius Kabi for the use of its SMOFlipid Lipid Injectable Emulsion in pediatric patients undergoing parenteral nutrition. The approval provided healthcare providers with an additional treatment option for pediatric patients requiring parenteral nutrition, potentially leading to improved patient outcomes and satisfaction.

Global Clinical Nutrition Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Product, Indication, Sales Channel, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Oral Clinical Nutrition
Enteral Feeding Formulas
Parenteral Nutrition

By Indication:
Alzheimer’s
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others

By Sales Channel:
Retail Sales Channels
Online Sales Channels
Institutional Sales Channels

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.